# Red Blood Cell Transfusion Strategies in Cardiovascular Interventions

## TL;DR

This paper reviews the use of blood transfusions in heart procedures and highlights the need for clearer evidence on their impact.

## Contribution

The paper provides a critical analysis of current transfusion strategies and identifies gaps in evidence for guiding clinical practice.

## Key findings

- Current transfusion practices lack strong evidence and clear guidelines.
- Observational and randomized studies show similar outcomes for liberal and restricted transfusion strategies.
- Future research should determine if transfusions actively cause or merely contribute to adverse events.

## Abstract

Acute coronary syndrome, cardiac surgery, and cardiac structural interventions
are among the most common situations leading to allogeneic red blood cell
consumption due to the prevalence of bleeding and anemia. The wide variability in
the use of transfusions derives from the current lack of data, and the absence of
strong evidence and clear guideline recommendations. The current approach is to
avoid unnecessary blood transfusions and limit their use to life-saving
conditions; this conservative strategy derives from often controversial and
inconclusive results of observational and randomized studies where liberal and
restricted red blood transfusion strategies seemed to have similar outcomes. The
pivotal question for future research lies in elucidating whether blood
transfusions function as an active participant or merely a catalyst in amplifying
adverse events. The present review aims to summarize the current literature data
and critically analyze the available evidence for red blood transfusions in
cardiac interventions.